ST BALDRICK'S FOUNDATION INC
Programs
Program 1 [2018]
THE ST. BALDRICK'S FOUNDATION IS THE LARGEST PRIVATE FUNDER OF CHILDHOOD CANCER RESEARCH GRANTS. WITH A RIGOROUS SCIENTIFIC REVIEW PROCESS, THESE GRANT TYPES WERE FUNDED: NEXT GENERATION TRAINING/RESEARCH: SUMMER FELLOWS, FELLOWSHIPS, SCHOLARS & INTERNATIONAL SCHOLARS. DISCOVERY RESEARCH: INFRASTRUCTURE, RESEARCH AND SUPPORTIVE CARE RESEARCH GRANTS. COOPERATIVE RESEARCH: CHILDREN'S ONCOLOGY GROUP AND OTHER RESEARCH CONSORTIA. OTHERS INCLUDE UNIQUE INNOVATION AWARDS IN MEMORY OF DR. ROBERT J. ARCECI, AND A ST. BALDRICK'S - STAND UP TO CANCER DREAM TEAM FUNDED TO CONTINUE TO USE GENOMICS TO DEVELOP NEW IMMUNOTHERAPIES. THE FOUNDATION ALSO PLAYS A LEADING ROLE IN THE CHILDHOOD CANCER COMMUNITY, ADVOCATING FOR MORE EFFECTIVE REGULATIONS AND FEDERAL FUNDING FOR CHILDHOOD CANCER RESEARCH. THE FOUNDATION MAKES DISEASE-SPECIFIC GRANTS AS WELL AS GRANTS AIMED AT MULTIPLE CHILDHOOD CANCERS AND ST. BALDRICK'S HAS FUNDED GRANTS TO STUDY ALL 12 MAJOR TYPES OF CHILDHOOD CANCERS AS WELL AS MANY SUB-TYPES.IN FY 2018, GRANTS WERE AWARDED IN THE FOLLOWING CATEGORIES:SCHOLARS - 5,264,824CONSORTIUM RESEARCH GRANTS - 2,352,737FELLOWSHIPS - 1,973,478INFRASTRUCTURE - 2,258,867INTERNATIONAL SCHOLARS - 1,005,000RESEARCH GRANTS - 2,587,744SUMMER FELLOWS - 95,000SUPPORTIVE CARE RESEARCH - 199,858COG - 6,439,837ROBERT J. ARCECI INNOVATION AWARD - 750,000ST. BALDRICK'S FOUNDATION INNOVATION AWARD - 450,000ROBERT J ARCECI INTERNATIONAL INNOVATION AWARDS - 1,050,000INTERNATIONAL BENEFICIARIES & DOMESTIC PARTNERS - 599,900GeographiesNot indicatedDatesJul 1, 2017 – Jun 30, 2018Source990No causes providedNo populations provided–$27.2MSt. Baldrick's Childhood Cancer Research Grants
THE ST. BALDRICK'S FOUNDATION IS THE LARGEST NON-GOVERNMENT FUNDER OF CHILDHOOD CANCER RESEARCH GRANTS. WITH A RIGOROUS SCIENTIFIC REVIEW PROCESS, THESE GRANT TYPES WERE FUNDED: NEXT GENERATION TRAINING/RESEARCH: FELLOWSHIPS, SCHOLARS & INTERNATIONAL SCHOLARS. DISCOVERY RESEARCH: RESEARCH AND INFRASTRUCTURE. COOPERATIVE RESEARCH: CHILDREN'S ONCOLOGY GROUP AND OTHER RESEARCH CONSORTIA. OTHERS INCLUDE SPECIFIC RESEARCH INITIATIVES FUNDED BY MAJOR DONORS AND AWARDED TO THE HIGHEST REVIEWED APPLICANTS, INTERNATIONAL BENEFICIARY AWARDS, A DATA COMMONS STRATEGIC INITIATIVE AWARD, AND A ST. BALDRICK'S EPICC TEAM (EMPOWERING PEDIATRIC IMMUNOTHERAPIES FOR CHILDHOOD CANCERS) FUNDED TO CONTINUE TO USE GENOMICS TO DEVELOP NEW IMMUNOTHERAPIES. (CONTINUED ON SCHEDULE O) THE FOUNDATION ALSO PLAYS A LEADING ROLE IN THE CHILDHOOD CANCER COMMUNITY, ADVOCATING FOR MORE EFFECTIVE POLICIES AND INCREASED FEDERAL FUNDING FOR CHILDHOOD CANCER RESEARCH. THE FOUNDATION MAKES DISEASE-SPECIFIC GRANTS AS WELL AS GRANTS AIMED AT MULTIPLE CHILDHOOD CANCERS AS WELL AS GRANTS AIMED AT TRAINING AND SUPPORTING THE WORK OF YOUNG INVESTIGATORS, DATA SHARING AND CANCER DISCIPLINES. WE LED THE EFFORT TO PASS THE CHILDHOOD CANCER STAR ACT AND WORKED WITH ADVOCATES AND THE CONGRESSIONAL CHILDHOOD CANCER CAUCUS TO SECURE CONTINUED FUNDING FROM CONGRESS. DURING THE YEAR WE ALSO LED THE SUCCESSFUL EFFORT TO REAUTHORIZE THE CHILDHOOD CANCER STAR ACT FOR AN ADDITIONAL FIVE YEARS. WE FURTHER WORKED WITH CONGRESSIONAL STAFF TO SECURE CONTINUED FUNDING FOR THE CHILDHOOD CANCER DATA INITIATIVE AND ENSURE THE FUNDS WERE APPROPRIATED. THESE EFFORTS RESULTED IN $80 MILLION IN ADDITIONAL FEDERAL FUNDS FOR CHILDHOOD CANCER RESEARCH FOR THE NCI AND CDC. WE WORKED WITH COALITIONS OF OTHER NONPROFITS SUPPORTIVE OF CHILDHOOD CANCER AND JOINTLY TRAINED VOLUNTEER ADVOCATES TO EDUCATE ELECTED OFFICIALS, LEGISLATIVE STAFF AND FEDERAL AGENCIES AS TO THE NEEDS OF CHILDREN WITH CANCER AND THE WORK OF THE RESEARCHERS ENDEAVORING TO SAVE THEM.IN FY 2023, GRANTS WERE AWARDED IN THE FOLLOWING CATEGORIES:SCHOLARS (YOUNG INVESTIGATOR AWARDS) 2,670,027INTERNATIONAL SCHOLARS 329,284CONSORTIUM RESEARCH GRANTS 1,459,737FELLOWSHIPS 1,310,726INFRASTRUCTURE 1,280,886CHILDREN'S ONCOLOGY GROUP 2,095,952RESEARCH GRANTS 1,799,999OSTEOSARCOMA RFA AWARD 1,500,000ST.BALDRICK'S EPICC TEAM (EMPOWERING PEDIATRIC IMMUNOTHERAPIES FOR CHILDHOOD CANCERS) 1,090,829INTERNATIONAL BENEFICIARIES & DOMESTIC PARTNERS 289,074ST. BALDRICK'S STATEGIC INITIATIVE GRANT 400,000AACR ST. BALDRICK'S FOUNDATION AWARD 75,000GeographiesNot indicatedDatesJul 1, 2022 – Jun 30, 2023Source990No causes providedNo populations provided–$15.6M
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)